West Pharmaceutical Services, Inc. logo
WSTWest Pharmaceutical Services, Inc.

Is the current ratio high or low?

The current ratio of 2.71 is 11% below its 5-year average of 3.05, near the low end of its 5-year range (2.34–3.80).

As of Saturday, June 27, 2026. 4.21% below its 12-month average of 2.83.

Current Ratio

WST Current Ratio

2.71

Reported quarterly current ratio; no daily interpolation.

-13.27% 5Y
WST Current Ratio

WST Average Current Ratio Chart

WST Current Ratio

WST Current vs Average Current Ratio Chart

WST Current Ratio Metrics

CURRENT RATIO

2.71

CURRENT RATIO AVG TTM

2.83

CURRENT RATIO AVG 3Y

2.83

CURRENT RATIO AVG 5Y

2.93

CURRENT RATIO AVG 10Y

2.82

CURRENT RATIO AVG 15Y

2.74

CURRENT RATIO AVG 20Y

2.65

CURRENT VS TTM AVG

-4.21%

CURRENT VS 3Y AVG

-4.11%

CURRENT VS 5Y AVG

-7.52%

CURRENT VS 10Y AVG

-3.80%

CURRENT VS 15Y AVG

-0.92%

CURRENT VS 20Y AVG

+2.29%

WST Competitors' Current Ratio

NAMEMARKET CAPCURRENT RATIOTTM3Y5Y
West Pharmaceutical Services, Inc. (WST)$24.79B2.712.832.832.93
Waters Corporation (WAT)vs ›$24.41B1.731.922.082.07
Mettler-Toledo International Inc. (MTD)vs ›$25.54B1.141.081.101.13
Quest Diagnostics Incorporated (DGX)vs ›$23.23B1.041.071.171.32
BioNTech SE (BNTX)vs ›$23.07B7.547.507.966.49
United Therapeutics Corporation (UTHR)vs ›$23.03B6.605.926.536.74
Moderna, Inc. (MRNA)vs ›$26.69B3.293.483.282.72
Incyte Corporation (INCY)vs ›$22.73B3.322.653.153.33
DexCom, Inc. (DXCM)vs ›$27.07B1.881.672.043.15
Labcorp Holdings Inc. (LH)vs ›$22.26B1.421.431.381.52

Liquidity Analysis

Current Ratio

2.71

Quick Ratio

2.34

Current Ratio Formula & Definition

Current Ratio = Current Assets / Current Liabilities

The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Current Ratio FAQ

What is the current ratio for West Pharmaceutical Services, Inc. (WST)?
The current ratio for WST stock is 2.71.
Is West Pharmaceutical Services, Inc.'s current ratio high or low?
The current ratio of 2.71 is 11% below its 5-year average of 3.05, near the low end of its 5-year range (2.34–3.80).
What is the TTM average current ratio for West Pharmaceutical Services, Inc. (WST)?
The TTM average current ratio for WST stock is 2.83.
What is the 3Y average current ratio for West Pharmaceutical Services, Inc. (WST)?
The 3Y average current ratio for WST stock is 2.83.
What is the 5Y average current ratio for West Pharmaceutical Services, Inc. (WST)?
The 5Y average current ratio for WST stock is 2.93.
What is the 10Y average current ratio for West Pharmaceutical Services, Inc. (WST)?
The 10Y average current ratio for WST stock is 2.82.
What is the 15Y average current ratio for West Pharmaceutical Services, Inc. (WST)?
The 15Y average current ratio for WST stock is 2.74.
What is the 20Y average current ratio for West Pharmaceutical Services, Inc. (WST)?
The 20Y average current ratio for WST stock is 2.65.

WST Current Ratio History

DATECURRENT RATIO
2026-03-312.71
2025-12-313.02
2025-09-302.87
2025-06-302.78
2025-03-312.77
2024-12-312.79
2024-09-303.00
2024-06-302.34
2024-03-312.61
2023-12-312.88
2023-09-303.70
2023-06-303.66
2023-03-313.62
2022-12-313.70
2022-09-303.80
2022-06-303.13
2022-03-312.89
2021-12-312.93
2021-09-302.86
2021-06-303.13
2021-03-312.75
2020-12-312.73
2020-09-302.77
2020-06-302.96
2020-03-312.84
2019-12-313.10
2019-09-303.00
2019-06-303.02
2019-03-312.88
2018-12-313.15
2018-09-302.94
2018-06-302.67
2018-03-312.82
2017-12-312.66
2017-09-302.59
2017-06-302.48
2017-03-312.54
2016-12-312.66
2016-09-302.78
2016-06-302.75
2016-03-312.62
2015-12-312.14
2015-09-302.27
2015-06-302.17
2015-03-312.11
2014-12-312.61
2014-09-302.80
2014-06-303.10
2014-03-313.02
2013-12-312.75
2013-09-302.61
2013-06-302.80
2013-03-312.83
2012-12-312.13
2012-09-302.02
2012-06-301.61
2012-03-311.66
2011-12-311.94
2011-09-302.20
2011-06-302.65
2011-03-312.63
2010-12-312.57
2010-09-302.79
2010-06-302.55
2010-03-312.20
2009-12-312.32
2009-09-302.45
2009-06-302.45
2009-03-312.57
2008-12-312.30
2008-09-302.48
2008-08-052.48
2008-03-312.70
2007-12-312.25
2007-09-302.69
2007-06-303.03
2007-03-312.82
2006-12-311.80
2006-09-301.80
2006-06-301.93
2006-03-311.97
2005-12-311.90
2005-09-301.78
2005-06-302.26
2005-03-312.25
2004-12-311.94
2004-09-302.04
2004-06-301.93
2004-03-311.77
2003-12-311.82
2003-09-301.86
2003-06-301.91
2003-03-311.86
2002-12-311.84
2002-09-302.06
2002-06-301.84

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Exton, PA
10,600 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Eric Green